Sirio Pharma Co., Ltd. (SHE:300791)

Market Cap	5.56B -6.4%
Revenue (ttm)	4.31B +2.3%
Net Income	117.80M -64.4%
EPS	0.39 -64.7%
Shares Out	307.02M
PE Ratio	46.95
Forward PE	14.90
Dividend	0.13 (0.72%)
Ex-Dividend Date	May 27, 2025

Volume	3,341,884
Open	17.11
Previous Close	17.13
Day's Range	16.99 - 18.45
52-Week Range	16.81 - 28.19
Beta	0.29
Analysts	Buy
Price Target	28.50 (+57.46%)
Earnings Date	Aug 21, 2026

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1993
• Employees: 2,776
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300791

Financial Performance

In 2025, Sirio Pharma's revenue was 4.26 billion, an increase of 1.23% compared to the previous year's 4.21 billion. Earnings were 136.53 million, a decrease of -58.00%.